Axitinib Impurity B (EP)

Axitinib Impurity B (EP)
GA01202 - 95%
In stock

Others quantities on request
Specifications
- CAS RN: 944835-85-2
- Purity: 95%
- Mol Formula: C15H13N3OS
- Mol Weight: 283.35
- Tags: Pharmaceutical Reference Substances and Impurities ; Axitinib ;
-
Description
GA01202
Axitinib is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in animal (xenograft) models[3] and has shown partial responses in clinical trials with renal cell carcinoma (RCC)[4] and several other tumour types.
We have successfully synthesized standards of the Axitinib. This will be of interest to pharmaceutical companies and analytical labs.
-
Additional information
Packing Unit 50 mg, 100 mg